Therapeutic Efficacy Evaluation of Radioimmunotherapy With 90 Y-Labeled Anti-Podoplanin Antibody NZ-12 for Mesothelioma

Cancer Science - United States
doi 10.1111/cas.13979
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Evaluation of Efficacy of Radioimmunotherapy With 90y-Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models

PLoS ONE
Multidisciplinary
2015English

Radioimmunotherapy of Infection With 213Bi-Labeled Antibodies

Current Radiopharmaceuticals
Nuclear MedicineRadiologyImagingPharmacology
2008English

Radioimmunotherapy for Model B Cell Malignancies Using 90y-Labeled Anti-Cd19 and Anti-Cd20 Monoclonal Antibodies

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Significant Therapeutic Efficacy With Combined Radioimmunotherapy and Cetuximab in Preclinical Models of Colorectal Cancer

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2015English

Evaluation of Cytotoxicity of Bispecific Antibody Against Mesothelioma

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

213Bi Radioimmunotherapy With an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2013English

Evaluation of Cytotoxicity of Bispecific Antibody Against Mesothelioma

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Anti-Cd30 Antibody Conjugated Liposomal Doxorubicin With Significantly Improved Therapeutic Efficacy Against Anaplastic Large Cell Lymphoma

Biomaterials
Mechanics of MaterialsBiophysicsBiomaterialsBioengineeringCompositesNanoscienceNanotechnologyCeramics
2013English

Bismuth-213 Radioimmunotherapy With C595 Anti–MUC1 Monoclonal Antibody in an Ovarian Cancer Ascites Model

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy